\begin{table}
\section*{Tables}

\begin{center}
%table 1
\caption{Steady state solutions of Hockin-Mann's model
\cite{HocJon02} with initial conditions specified in
\cite{HocJon02}. See Table \ref{tabb} in Appendix A for definition
of variables.}\label{steady}\vspace{3mm}
\begin{tabular}{|c|c|}\hline
Constant solutions &$x_1=x_3=x_5=x_6=x_7=x_8=x_9=x_{10}=x_{12}=x_{18}=x_{23}=x_{24}=0,$\\
 & $x_{25}=x_{27}=x_{28}=x_{29}=0,x_{26}=8.33\times10^{-10},x_{30}=5.33\times 10^{-9},x_{34}=2.5\times 10^{-11}$\\\hline
Free variables &$x_4,  x_{11},x_{13}, x_{14},x_{15},x_{16}, x_{17},
x_{21},x_{33}$\\\hline Linear
expression&$x_{2}=3.3383\times10^{-9}-x_{4}$,\quad  $x_{19}=x_{20}=2.33\times10^{-10}-x_{15}-x_{16}-x_{17}$\\
&$ x_{22}=6.67\times10^{-9}-x_{21},\quad x_{31}=4.67\times10^{-7}-x_{14}-x_{33}$\\
&$ x_{32}=3\times10^{-8}-x_{11}-x_{13}-x_{17}$\\\hline Other
equations&$k_{18}x_{17}+k_{25}x_{17}-k_{19}x_{16}x_{13}=0,k_{18}x_{17}-k_{24}x_{16}+k_{23}x_{19}x_{20}-k_{19}x_{16}x_{13}=0$\\\hline
\end{tabular}

%table 2
\caption{Max eigenvalues for $A_i$} \vspace{3mm} \label{eig}
\begin{tabular}{|c|c|c|c|c|c|c|c|}\cline{1-2}
\cline{4-5}\cline{7-8}
$\max(\rho(A_1))$&-4.3e-19&&$\max(\rho(A_7))$&-7.1e-06&&$\max(\rho(A_{13}))$&-4.9e-07\\\cline{1-2}\cline{4-5}\cline{7-8}
$\max(\rho(A_{18}))$&-1.1e-04&&$\max(\rho(A_{24}))$&-1.1e-04&&$\max(\rho(A_{30}))$&-1.1e-04\\\cline{1-2}\cline{4-5}\cline{7-8}
$\max(\rho(A_2))$&-1.1e-04&&$\max(\rho(A_8))$&-1.1e-04&&$\max(\rho(A_{14}))$&-1.1e-04\\\cline{1-2}\cline{4-5}\cline{7-8}
$\max(\rho(A_{19}))$&-1.1e-04&&$\max(\rho(A_{25}))$&-7.1e-06&&$\max(\rho(A_{31}))$&-1.1e-04\\\cline{1-2}\cline{4-5}\cline{7-8}
$\max(\rho(A_3))$&-1.1e-04&&$\max(\rho(A_9))$&-1.1e-04&&$\max(\rho(A_{15}))$&-1.1e-04\\\cline{1-2}\cline{4-5}\cline{7-8}
$\max(\rho(A_{20}))$&-1.1e-04&&$\max(\rho(A_{26}))$&-1.8e-20&&$\max(\rho(A_{32}))$&-1.1e-04\\\cline{1-2}\cline{4-5}\cline{7-8}
$\max(\rho(A_4))$&-4.3e-19&&$\max(\rho(A_{10}))$&-3.6e-04&&$\max(\rho(A_{16}))$&-1.1e-04\\\cline{1-2}\cline{4-5}\cline{7-8}
$\max(\rho(A_{21}))$&-1.1e-04&&$\max(\rho(A_{27}))$&-6.4e-06&&$\max(\rho(A_{33}))$&-1.1e-04\\\cline{1-2}\cline{4-5}\cline{7-8}
$\max(\rho(A_5))$&-2.3e-07&&$\max(\rho(A_{11}))$&-1.1e-04&&$\max(\rho(A_{17}))$&-1.1e-04\\\cline{1-2}\cline{4-5}\cline{7-8}
$\max(\rho(A_{22}))$&-1.1e-04&&$\max(\rho(A_{28}))$&-1.1e-04&&$\max(\rho(A_{34}))$&-1.1e-04\\\cline{1-2}\cline{4-5}\cline{7-8}
$\max(\rho(A_6))$&-1.5e-06&&$\max(\rho(A_{12}))$&-1.1e-04&&&\\\cline{1-2}\cline{4-5}\cline{7-8}
$\max(\rho(A_{23}))$&-1.1e-04&&$\max(\rho(A_{29}))$&-4.9e-07&&&\\\cline{1-2}\cline{4-5}\cline{7-8}
\end{tabular}

\caption{Steady state solution by setting free variables be zeros in
Table \ref{steady}} \label{steady2}\vspace{3mm}
%table 3
\begin{tabular}{|c|c|}\hline
zero solutions&$x_1=x_3=x_4=x_5=x_6=x_7=x_8=x_9=x_{10}=x_{11}=x_{12}= x_{14}=0,$\\
&
$x_{15}=x_{18}=x_{21}=x_{23}=x_{24}=x_{25}=x_{27}=x_{28}=x_{29}=x_{32}=x_{33}=0$\\\hline
constant solutions&$x_{2}=3.3383\times10^{-9},
x_{22}=6.67\times10^{-9},
x_{26}=8.33\times10^{-10}$,\\
&$x_{30}=5.33\times
10^{-9},x_{31}=4.67\times10^{-7},x_{34}=2.5\times 10^{-11}$\\\hline
polynomial system &$
3\times10^{-8}-x_{13}-x_{17}=0$\\
&$k_{18}x_{17}+k_{25}x_{17}-k_{19}x_{16}x_{13}=0$\\&$k_{18}x_{17}-k_{24}x_{16}+k_{23}x_{19}x_{20}-k_{19}x_{16}x_{13}=0$\\\hline
linear
equation&$x_{19}=x_{20}=2.33\times10^{-10}-x_{16}-x_{17}$\\\hline
\end{tabular}
%table 4
\caption{The relative difference of nonzero components of the steady
state solution shown in \ref{steady2} compared with the solution
computed by time marching } \label{RE}\vspace{3mm}
\begin{tabular}{|c|c|c|c|c|}\cline{1-2}
\cline{4-5} $x_i$&relative difference&&$x_i$&relative difference \\
\cline{1-2} \cline{4-5} $x_2$& 4.67582e-08&&$x_{22}$ &
7.70551e-09\\\cline{1-2} \cline{4-5}
 $x_{13}$& 1.84436e-08&&$x_{26}$
& 3.94895e-09\\\cline{1-2} \cline{4-5}
  $x_{16}$&    7.40565e-08&&$x_{30}$ & 8.09857e-08\\\cline{1-2} \cline{4-5}
  $x_{17}$&    4.58548e-08&&$x_{31}$ & 6.09728e-08\\\cline{1-2} \cline{4-5}
  $x_{19}$&     7.49401e-08&&$x_{34}$ & 4.63122e-08\\\cline{1-2} \cline{4-5}
  $x_{20}$&    7.49401e-08&&&\\\cline{1-2} \cline{4-5}
\end{tabular}
\end{center}
\end{table}

\begin{table}
\begin{center}

%table 5
 \caption{Nonlinear stability of the steady state solution shown in Table \ref{steady2}}\vspace{3mm}\label{sta}
\begin{tabular}{|c|c|}\hline
perturbation $\epsilon_n$& $\|\tilde{x}-x_s\|$\\\hline
$O(10^{-6})$&$1.67733\times10^{-5}$\\\hline
$O(10^{-7})$&$1.33397\times10^{-6}$\\\hline
$O(10^{-8})$&$3.59671\times10^{-7}$\\\hline
\end{tabular}

\caption{Steady state solutions using initial conditions from
\cite{KF01}} \label{steady21}\vspace{3mm}
\begin{tabular}{|c|c|}\hline
Constant solutions &$x_1=x_3=x_5=x_6=x_7=x_8=x_9=x_{10}=x_{12}=x_{18}=x_{23}=x_{24}=x_{25}=0,$\\
 & $x_{27}=x_{28}=x_{29}=0,x_{26}=4.66\times10^{-9},x_{30}=3.25\times 10^{-8},x_{34}=3.1\times 10^{-10}$\\\hline
Free variables &$x_4,  x_{11},x_{13}, x_{14},x_{15},x_{16}, x_{17},
x_{21},x_{33}$\\\hline Linear
expression&$x_{2}=6.45\times10^{-8}-x_{4}$,\quad  $x_{19}=x_{20}=4.31\times10^{-9}-x_{15}-x_{16}-x_{17}$\\
&$ x_{22}=3.33\times10^{-8}-x_{21},\quad x_{31}=5.32\times10^{-6}-x_{14}-x_{33}$\\
&$ x_{32}=5\times10^{-7}-x_{11}-x_{13}-x_{17}$\\\hline Other
equations&$k_{18}x_{17}+k_{25}x_{17}-k_{19}x_{16}x_{13}=0$,\\&$k_{18}x_{17}-k_{24}x_{16}+k_{23}x_{19}x_{20}-k_{19}x_{16}x_{13}=0$\\\hline
\end{tabular}

\caption{Steady state solutions by setting free variables in Table
\ref{steady21} to zeros}\label{steady22}\vspace{3mm}
\begin{tabular}{|c|c|}\hline
zero solutions&$x_1=x_3=x_5=x_6=x_7=x_8=x_9=x_{10}=x_{12}=x_{18}=x_{23}=x_{24}=0,$\\
& $x_{25}=x_{27}=x_{28}=x_{29}=0=x_4=x_{11}=
 x_{14}=x_{15}=x_{21}=x_{32}=x_{33}=0$\\\hline
constant solutions&
$x_{2}=6.45\times10^{-8},x_{22}=3.33\times10^{-8},x_{26}=4.66\times10^{-9},x_{30}=3.25\times
10^{-8},$ \\
&$x_{31}=5.32\times10^{-6},x_{34}=3.1\times 10^{-10}$\\\hline
polynomial system &$
5\times10^{-7}-x_{13}-x_{17}=0$\\
&$k_{18}x_{17}+k_{25}x_{17}-k_{19}x_{16}x_{13}=0$\\&$k_{18}x_{17}-k_{24}x_{16}+k_{23}x_{19}x_{20}-k_{19}x_{16}x_{13}=0$\\\hline
linear
equation&$x_{19}=x_{20}=4.31\times10^{-9}-x_{16}-x_{17}$\\\hline
\end{tabular}

\caption{Listing of reaction rates analyzed in Hockin-Mann's model.
These values are obtained by fitting computational results to
empirical data. } \vspace{3mm} \label{reactrate}
\begin{tabular}{|c|c|c|}\hline
Rate no.& Lower bound& Upper bound\\\hline 1& $6.29\times 10^{-4}$&
$3.1\times 10^{-3}$\\\hline 2& $1.6\times 10^{5}$& $3.2\times
10^{6}$\\\hline 3& $8.76\times 10^{-4}$& $3.1\times
10^{-3}$\\\hline4& $1.6\times 10^{5}$& $2.3\times 10^{7}$\\\hline 8&
69 nm(PCPS)& 4.35 $\mu$m(PC)\\\hline 9& 69 nm(PCPS)& 4.35
$\mu$m(PC)\\\hline 11& 17 & 21\\\hline
 12&
$2\times 10^7$& $2.4\times 10^7$\\\hline
 13&
2.1& 2.7\\\hline
 14&$9\times10^6$& $1.1\times10^7$\\\hline
 15&1.6& 2\\\hline
 23&$2\times10^4$& $2.4\times10^4$\\\hline
 34&$8\times10^5$& $1\times10^6$\\\hline
  35&$1\times10^{-4}$& $1.2\times10^{-4}$\\\hline
 36&$2.9\times10^8$& $3.5\times10^8$\\\hline
 37&$4.5\times10^7$& $5.5\times10^7$\\\hline
\end{tabular}
\end{center}
\end{table}
\vspace{-10in}
\begin{table}
\begin{center}
 \caption{Clinical trials information for factor IX, was assembled from http://ClinicalTrials.gov using the search terms
factor IX, where both open and closed trials were accepted.
}\label{tab:trial}
 \vspace{3mm}
\begin{tabular}{|c|c|c|c|}\hline
Trial Identifier&Condition&Intervention&Purpose\\\hline
NCT00581126&Hemophilia B&Recombinant Factor &To assess efficacy and
safety of BeneFix\\&&IX Coagulation & for prophylaxis in
"Short-term" therapy
\\&&&and on demand therapy for all bleeding
\\&&&episodes of subjects with hemophilia B \\\hline
NCT00004801&Hemophilia B&monoclonal factor IX &Assess the safety and
long-term efficacy \\& Factor IX Deficiency&replacement therapy&of
monoclonal factor IX concentrate in \\&&&patients with factor IX
deficiency.\\\hline NCT00000582&Blood Coagulation Disorders&Factor
IX&To test the efficacy of prothrombin
\\&Hematologic Diseases &&complex concentrates (Factor IX) in the  \\&Hemorrhagic Disorders
&&treatment of hemophiliac patients who\\&&& had inhibitors to
Factor VIII.\\\hline NCT01159210&Prothrombin Complex&Prothrombin
complex &To assess the efficacy and safety of\\& Factor Deficiency
&concentrate& Prothromplex Total as a treatment \\&&&for the
immediate reversal of oral\\&&&  anticoagulant therapy with vitamin
K  \\&&&antagonists in patients with acquired \\&&&deficiency of
prothrombin complex \\&&&coagulation factors (II, VII, IX,
X).\\\hline
\end{tabular}
\end{center}
\end{table}
